cetuximab

INN (International Nonproprietary Name)

🇺🇸 Also approved in the US (FDA)

ERBITUX — IMCLONE, approved 2021-09-24 (BLA125084).

Most reported adverse events (US / FAERS)

20,074 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.

rash

2,256

diarrhoea

2,000

off label use

1,854

nausea

1,633

vomiting

Medicines containing this active substance

1 medicines

Erbitux

Authorised

🇺🇸 Also approved in the US (FDA)

ERBITUX — IMCLONE, approved 2021-09-24 (BLA125084).

Most reported adverse events (US / FAERS)

20,074 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.

rash

2,256

diarrhoea

2,000

off label use

1,854

nausea

1,633

vomiting

1,382

dyspnoea

1,375

neutropenia

1,213

pyrexia

1,118

dehydration

1,103

infusion related reaction

1,099

malignant neoplasm progression

1,084

death

1,063

fatigue

1,062

hypotension

919

anaemia

913